NYSE: AHR · Healthcare Facility REITs
American Healthcare REIT (AHR) fair value and price range
As of 16 Nov 2026, Faircurve's model values American Healthcare REIT (AHR) at $22.90 a share. The stock last closed at $58.07, which puts the model's fair value 60.6% below the price. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
Revalued . Price is the close of 16 Nov 2026. American Healthcare REIT, Inc.
The report adds the live price, the chart against the range the options market prices and the next earnings date. No account needed.
This week, in three parts
What happenedThe run of 16 Nov 2026 moved the fair value from $24.21 to $22.90 (-5.4%). The model does not yet explain moves on this valuation method.
What the model makes of itThe price of $58.07 is 60.6% above it. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
What's nextNext report on 25 Feb 2027. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give AHR?
The calibrated range for AHR over 63 trading days is $18.31 to $27.21. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 13,250 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon.
The price is above this range. For names with fair value 15%+ below price, the calibrated range has held the price 33% of the time over 63 trading days, and 66% ended above it; the typical move was −4.9%.
The model's own range is $21.25 to $24.71.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does AHR report earnings, and how has the stock reacted?
American Healthcare REIT's next earnings report is scheduled for 25 Feb 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 12.8% in either direction through the nearest expiry, about 59 days out. That is the size the market is pricing, not a direction.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across AHR's last 8 reports, ignoring direction, was 2.2%.
How does AHR compare with similar companies?
The companies in healthcare facility reits closest to American Healthcare REIT in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| DOC Healthpeak Properties, Inc. | $19.84 | $31.13 | +56.9% | Undervalued |
| OHI Omega Healthcare Investors, Inc. | $47.08 | $51.39 | +9.2% | Undervalued |
| CTRE CareTrust REIT, Inc. | $37.39 | $33.28 | -11.0% | Overvalued |
| HR Healthcare Realty Trust Incorporated | $19.32 | $17.48 | -9.5% | Overvalued |
| SBRA Sabra Health Care REIT, Inc. | $20.35 | $20.72 | +1.8% | Fairly valued |
| VTR Ventas, Inc. | $88.90 | $46.80 | -47.4% | Overvalued |
| LTC LTC Properties, Inc. | $42.71 | $56.30 | +31.8% | Undervalued |
| WELL Welltower Inc. | $244.78 | $75.03 | -69.3% | Gap wider than 60% |
All healthcare facility reit stocks ranked by gap to fair value
American Healthcare REIT at a glance
American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare.
- Market value
- $13.4B
- Sector
- Real Estate
- Industry
- Healthcare Facility REITs
- Beta to the US market
- -0.03
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model values American Healthcare REIT three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for AHR was $24.21. As of 16 Nov 2026 it is $22.90, a change of -5.4%. The model does not yet explain moves on this valuation method. The model revalues every stock it covers each week, and again after an earnings report.
Questions about American Healthcare REIT's valuation
Is American Healthcare REIT stock undervalued or overvalued?
Faircurve's model puts AHR's fair value at $22.90 a share against a last close of $58.07, as of 16 Nov 2026. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
What is AHR's fair value?
$22.90 a share as of 16 Nov 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $21.25 to $24.71.
What price range does the model give AHR?
$18.31 to $27.21 over 63 trading days. Ranges built this way held the price 60% of the time across 13,250 past valuations, refreshed 14 Nov 2026.
When does American Healthcare REIT report earnings next?
The next report is scheduled for 25 Feb 2027. Companies can move their dates.
How much has AHR moved on past earnings reports?
Across its last 8 reports the median two session move was 2.2%, ignoring direction. The largest was +4.9% around the report of 6 Nov 2025.
How confident is the model in this valuation?
The model's evidence grade for AHR is low. For real estate investment trusts (REITs) the grade looks at the dividend record: at least three years of paid dividends with no cut. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on AHR
The model holds no idea open on AHR today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on AHR with their outcomes. A free account is enough.